Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hidemitsu Kitamura
Observed names:
H Kitamura,
H. KITAMURA,
H. Kitamura,
Hidemitsu KITAMURA,
Kitamura, Hidemitsu
Institution:
Toyo University
Observed institutions:
Tokai University,
Howard Hughes Medical Institute,
Toyo University,
Vanderbilt University,
Hokkaido University,
National Jewish Health,
Juntendo University,
RIKEN,
Bioimmulance Co., Ltd. (Japan),
The University of Osaka
show all 10
ORCID:
0000-0001-7006-6767
Observed ORCID:
0000-0001-7006-6767
OpenAlex ID:
A5032677862
The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells
1999
·
Hidemitsu Kitamura
, Kenji Iwakabe
, et al.
·
The Journal of Experimental Medicine
·
626
IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation
2004
·
Sung-Joo Park
, Takayuki Nakagawa
, et al.
·
The Journal of Immunology
·
519
PDF
Toll-like receptor–mediated regulation of zinc homeostasis influences dendritic cell function
2006
·
Hidemitsu Kitamura
, Hideyuki Morikawa
, et al.
·
Nature Immunology
·
355
Interleukin‐6/ STAT 3 signaling as a promising target to improve the efficacy of cancer immunotherapy
2017
·
Hidemitsu Kitamura
, Yosuke Ohno
, et al.
·
Cancer Science
·
278
PDF
Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy
2010
·
Tsuguhide Takeshima
, Kenji Chamoto
, et al.
·
Cancer Research
·
243
PDF
Tumor‐infiltrating IL‐17‐producing γδ T cells support the progression of tumor by promoting angiogenesis
2010
·
Daiko Wakita
, Kentaro Sumida
, et al.
·
European Journal of Immunology
·
236
The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
2000
·
Takashi Nishimura
, Hidemitsu Kitamura
, et al.
·
International Immunology
·
225
IL-6-STAT3 Controls Intracellular MHC Class II αβ Dimer Level through Cathepsin S Activity in Dendritic Cells
2005
·
Hidemitsu Kitamura
, Hokuto Kamon
, et al.
·
Immunity
·
223
PDF
IL-6–dependent spontaneous proliferation is required for the induction of colitogenic IL-17–producing CD8+ T cells
2008
·
Masaki Tajima
, Daiko Wakita
, et al.
·
The Journal of Experimental Medicine
·
166
α-Galactosylceramide Induces Early B-Cell Activation through IL-4 Production by NKT Cells
2000
·
Hidemitsu Kitamura
, Akio Ohta
, et al.
·
Cellular Immunology
·
144
Zinc Is Required for FcεRI-Mediated Mast Cell Activation
2006
·
Koki Kabu
, Satoru Yamasaki
, et al.
·
The Journal of Immunology
·
127
Anti‐ IL ‐6 receptor m A b eliminates myeloid‐derived suppressor cells and inhibits tumor growth by enhancing T ‐cell responses
2012
·
Kentaro Sumida
, Daiko Wakita
, et al.
·
European Journal of Immunology
·
126
PDF
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells
2016
·
Yosuke Ohno
, Hidemitsu Kitamura
, et al.
·
Cancer Immunology Immunotherapy
·
118
PDF
1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells
2010
·
Utako Ikeda
, Daiko Wakita
, et al.
·
Immunology Letters
·
110
IL6 Modulates the Immune Status of the Tumor Microenvironment to Facilitate Metastatic Colonization of Colorectal Cancer Cells
2019
·
Yujiro Toyoshima
, Hidemitsu Kitamura
, et al.
·
Cancer Immunology Research
·
85
PDF
Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy
2017
·
Yosuke Ohno
, Yujiro Toyoshima
, et al.
·
Cancer Science
·
82
PDF
The Key Role of IL-6–Arginase Cascade for Inducing Dendritic Cell–Dependent CD4+ T Cell Dysfunction in Tumor-Bearing Mice
2012
·
Yoshinori Narita
, Hidemitsu Kitamura
, et al.
·
The Journal of Immunology
·
81
IL-17/IFN- double producing CD8+ T (Tc17/IFN- ) cells: A novel cytotoxic T-cell subset converted from Tc17 cells by IL-12
2011
·
M. Tajima
, D. Wakita
, et al.
·
International Immunology
·
78
PDF
Essential role of Toll-like receptors for dendritic cell and NK1.1+ cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84
2008
·
Shin-ichi Koizumi
, Daiko Wakita
, et al.
·
Immunology Letters
·
76
Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a Th17-independent manner
2007
·
D. Noguchi
, D. Wakita
, et al.
·
International Immunology
·
76
PDF
First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen
2012
·
Norihiko Takahashi
, Takayuki Ohkuri
, et al.
·
Cancer Science
·
61
PDF
TRIF–GEFH1–RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T‐cell activation
2006
·
Hokuto Kamon
, Takaya Kawabe
, et al.
·
The EMBO Journal
·
61
PDF
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
2021
·
Akemi Kosaka
, Kei Ishibashi
, et al.
·
The Journal of Experimental Medicine
·
55
KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR
2015
·
Daisuke Kamimura
, Kokichi Katsunuma
, et al.
·
Nature Communications
·
51
PDF
Combination immunotherapy with radiation and CpG‐based tumor vaccination for the eradication of radio‐ and immuno‐resistant lung carcinoma cells
2009
·
Kenji Chamoto
, Tsuguhide Takeshima
, et al.
·
Cancer Science
·
42
PDF
Show more works
View as search
Works count:
139
Citation count:
5,215
H-index:
32
I10-index:
67
Year
Topic
Type
